sec filing
AP
NASDAQ · APVO
Aptevo Therapeutics Inc.
Healthcare · Biotechnology
$1.83
Down-$0.00 (-0.21%)
Updated Sep 11, 2026, 11:39 AM
SID Score
3.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 12.03M
- P/E ratio
- -0.06
- Dividend yield
- 0.00%
- 52-week range
- $1.37 – $6.74
- Volume
- 56.83K
- Avg. volume
- 182.09K
Price performance
APVO price history
1M range · 20 trading sessions · Daily adjusted prices
APVO closed at $1.83 after 20 trading sessions, down 46.18% for the selected period.
- Last close
- $1.83
- Period change
- -46.18%
- Period low
- $1.71
- Period high
- $3.40
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | $1.82 | $1.88 | $1.76 | $1.83 | 56.83K |
| Sep 9, 2026 | $1.89 | $1.99 | $1.82 | $1.845 | 43.91K |
| Sep 8, 2026 | $1.77 | $1.93 | $1.7447 | $1.88 | 168.84K |
| Sep 4, 2026 | $1.74 | $1.7961 | $1.64 | $1.74 | 272.97K |
| Sep 3, 2026 | $2.11 | $2.18 | $1.37 | $1.71 | 1.69M |
| Sep 2, 2026 | $2.34 | $2.77 | $2.33 | $2.60 | 1.03M |
| Sep 1, 2026 | $2.44 | $2.44 | $2.34 | $2.34 | 31.99K |
| Aug 31, 2026 | $2.35 | $2.45 | $2.35 | $2.44 | 29.79K |
| Aug 28, 2026 | $2.46 | $2.46 | $2.31 | $2.365 | 21.68K |
| Aug 27, 2026 | $2.41 | $2.42 | $2.34 | $2.42 | 35.35K |
| Aug 26, 2026 | $2.49 | $2.5499 | $2.41 | $2.41 | 28.05K |
| Aug 25, 2026 | $2.37 | $2.50 | $2.3006 | $2.46 | 58.6K |
| Aug 24, 2026 | $2.76 | $2.76 | $2.38 | $2.41 | 194.99K |
| Aug 21, 2026 | $2.84 | $2.85 | $2.5801 | $2.68 | 55.3K |
| Aug 20, 2026 | $2.74 | $2.9115 | $2.7233 | $2.76 | 63.85K |
| Aug 19, 2026 | $2.99 | $3.01 | $2.60 | $2.73 | 92.62K |
| Aug 18, 2026 | $2.82 | $2.90 | $2.68 | $2.90 | 48.63K |
| Aug 17, 2026 | $2.99 | $2.99 | $2.8099 | $2.81 | 54.76K |
| Aug 14, 2026 | $3.40 | $3.40 | $2.84 | $2.94 | 79.54K |
| Aug 13, 2026 | $3.5043 | $3.56 | $3.35 | $3.40 | 33.93K |
Latest APVO news
The latest Smart Investors Daily articles mentioning APVO.
Stock researchMarket Activity · Institutional Ownership
Loading stock research…

